ANXA1 and astrocytoma (excluding glioblastoma): Triple immunofluorescence analysis of additional patient samples revealed elevated levels of ANXA1 protein in GFAP+ cells but not in CD31+ blood vessels in GBM samples in comparison to G.2 and G.3 astrocytoma samples (Supplementary Fig. 14B).